Citation Impact
Citing Papers
Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall
2009
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration
2005 StandoutScience
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
2008 StandoutScience
Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.
2002
Cadherins in collective cell migration of mesenchymal cells
2012
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
2011
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Optical coherence tomography angiography
2017 Standout
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19
2004
Diabetic retinopathy
2010 Standout
Inhibitors of Ocular Neovascularization
2005
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
2015 Standout
Adenosine receptor‐induced cAMP changes in D384 astrocytoma cells and the effect of bradykinin thereon
1992
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide
2004
Age-Related Macular Degeneration
2008 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Extracellular matrix, inflammation, and the angiogenic response
2010
Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration
2005
Purinergic regulation of cation conductances and intracellular Ca2+ in cultured rat retinal pigment epithelial cells
1999
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Hydrogen Peroxide Causes Significant Mitochondrial DNA Damage in Human RPE Cells
1999
Intrachoroidal Neovascularization in Transgenic Mice Overexpressing Vascular Endothelial Growth Factor in the Retinal Pigment Epithelium
2001
Regulation of retinal blood flow in health and disease
2008
The biology of VEGF and its receptors
2003 Standout
IGF-1–Induced VEGF and IGFBP-3 Secretion Correlates with Increased HIF-1α Expression and Activity in Retinal Pigment Epithelial Cell Line D407
2004
Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies
2003
Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
2006
Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
1997
Recent progress in ocular drug delivery for posterior segment disease: Emphasis on transscleral iontophoresis
2005
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Macular pigment and age related macular degeneration
1999
Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity
2000 StandoutNobel
Age-related macular degeneration
2012 Standout
Renewal of photoreceptor outer segments and their phagocytosis by theretinal pigment epithelium
2000
Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy
2010
Retinal and choroidal neovascularization
2000
THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASE
2005
Diabetic Retinopathy
2012 Standout
REVIEW ARTICLE, Immunological Factors in the Pathogenesis and Treatment of Age-Related Macular Degeneration
2005
Localization of Collagen XVIII and the Endostatin Portion of Collagen XVIII in Aged Human Control Eyes and Eyes with Age-Related Macular Degeneration
2004
Release of ATP by a human retinal pigment epithelial cell line: potential for autocrine stimulation through subretinal space
2001
Pharmacotherapy for Neovascular Age-Related Macular Degeneration: An Analysis of the 100% 2008 Medicare Fee-For-Service Part B Claims File
2011
Vascular Endothelial Growth Factor: Molecular and Biological Aspects
1999
Osteoblast Precursors, but Not Mature Osteoblasts, Move into Developing and Fractured Bones along with Invading Blood Vessels
2010
A Broad-Spectrum Inhibitor of CRISPR-Cas9
2017 StandoutNobel
Mechanisms of Age-Related Macular Degeneration
2012
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists
1996
Molecular and biological properties of vascular endothelial growth factor
1999
Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization
1999
Structure and function of adenosine receptors and their genes
2000
Vascular Endothelial Growth Factor Family and Receptor Expression in Human Choroidal Neovascular Membranes
2002
Matrix metalloproteinases as modulators of inflammation and innate immunity
2004 Standout
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
2006 Standout
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Choroidal neovascularization
2004
Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration
2006
TGFβ in Cancer
2008 Standout
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
Memory of Extracellular Adenosine A2A Purinergic Receptor-mediated Signaling in Murine T Cells
1997 StandoutNobel
Current Concepts in the Pathogenesis of Age-Related Macular Degeneration
2004
The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration
2008
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α
1998 StandoutNobel
Pegaptanib for Neovascular Age-Related Macular Degeneration
2004 Standout
Vascular endothelial growth factors and angiogenesis in eye disease
2003
Dexamethasone intravitreal implant as adjunct therapy for patients with wet age-related macular degeneration with incomplete response to ranibizumab
2014
COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
2009
VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration
2009
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
2017
Regulatory role of HIF-1α in the pathogenesis of age-related macular degeneration (AMD)
2009
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
Developmental and Pathological Angiogenesis
2011
VEGF and Intraocular Neovascularization: From Discovery to Therapy
2016
Role of tissue stroma in cancer cell invasion
2003
Matrix metalloproteinases and tumor metastasis
2006 Standout
Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor
1998 Standout
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
2013 StandoutNature
Prevention of Experimental Choroidal Neovascularization With Intravitreal Anti–Vascular Endothelial Growth Factor Antibody Fragment
2002
Vascular endothelial growth factor and ocular neovascularization.
1997
The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes.
1999
Aptamers: An Emerging Class of Therapeutics
2005
MMP‐2 and MMP‐9 synergize in promoting choroidal neovascularization
2003
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Functional Nucleic Acid Sensors
2009 Standout
Placental Growth Factor, a Member of the VEGF Family, Contributes to the Development of Choroidal Neovascularization
2003
Quantum indistinguishability by path identity and with undetected photons
2022 StandoutNobel
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Reduced Retinal Angiogenesis in MMP-2–Deficient Mice
2003
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells.
2002
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 StandoutScience
Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration
2005
Choroidal neovascularization: a wound healing perspective.
2003
Role of hypoxia and extracellular matrix‐integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells
1999
Mechanisms of Vessel Branching
2009
Effect of Intravitreal Injection of Ranibizumab in Combination with Verteporfin PDT on Normal Primate Retina and Choroid
2005
Cancer Genome Landscapes
2013 StandoutScience
Chapter 11 Adenosine and Neuroprotection
1996
Cyclic Stretch and Hypertension Induce Retinal Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor—2
2001
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
2001 Standout
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
2011 Standout
Growth factors and their receptors in the retina and pigment epithelium
1997
Pharmacologic and Genetic Manipulation of MMP-2 and -9 Affects Retinal Neovascularization in Rodent Models of OIR
2007
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
CRISPR-Cas guides the future of genetic engineering
2018 StandoutScienceNobel
Works of Anders Kvanta being referenced
Localization of Adenosine Receptor Messenger RNAs in the Rat Eye
1997
Biomechanical regulation of blood vessel growth during tissue vascularization
2009
Angiomotin regulates endothelial cell migration during embryonic angiogenesis
2007
Ocular angiogenesis: the role of growth factors
2006
CD3/T‐cell receptor coupling to a pertussis and cholera toxin‐insensitive G‐protein
1989
Role of a pertussis toxin sensitive G-protein in mediating the effects of phorbol esters on receptor activated cyclic AMP accumulation in Jurkat cells
1991
Further evidence that propentofylline (HWA 285) influences both adenosine receptors and adenosine transport
1992
Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts
1995
Retinal Vascular Development and Pathologic Retinal Angiogenesis Are Not Impaired in Matrix Metalloproteinase-2 Deficient Mice
2005
Expression and Secretion of Transforming Growth Factor-β in Transformed and Nontransformed Retinal Pigment Epithelial Cells
1994
A prospective study on intravitreal bevacizumab (Avastin®) for neovascular age‐related macular degeneration of different durations
2008
Expression of Matrix Metalloproteinase-2 (MMP-2) and Vascular Endothelial Growth Factor (VEGF) in Inflammation-associated Corneal Neovascularization
2000
Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice
2004
Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor
1996
Optical Coherence Tomography Angiography in Central Retinal Vein Occlusion: Correlation Between the Foveal Avascular Zone and Visual Acuity
2016
Age‐related Macular Degeneration
2004
Interactions between adenosine receptors and other membrane receptors
1990
Hypoxia-Inducible Factor-1α Is Associated With Sprouting Angiogenesis in the Murine Laser-Induced Choroidal Neovascularization Model
2015
Structure and function of the N-cadherin/catenin complex in retinoblastoma.
2002
Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes.
1998
Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization
2000
Dual effects of protein kinase-C on receptor-stimulated cAMP accumulation in a human T-cell leukemia line
1989
Reduced Choroidal Neovascular Membrane Formation in Matrix Metalloproteinase-2–Deficient Mice
2003
Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor.
1996